Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 2 |
2021 | 4 |
2022 | 1 |
2024 | 1 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Reply to Andreas Boehle, Frank Kahmann, Thomas Oliver Henkel, Joerg Zimmermann and Stefan Machten's to the Letter to the editor Re: results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial).
J Cancer Res Clin Oncol. 2021 Apr;147(4):1273-1274. doi: 10.1007/s00432-021-03549-y.
J Cancer Res Clin Oncol. 2021.
PMID: 33625578
Free PMC article.
No abstract available.
Ex Vivo Fluorescence Confocal Microscopy (FCM) Ensures Representative Tissue in Prostate Cancer Biobanking: A Feasibility Study.
Titze U, Sommerkamp J, Stege C, Schneider F, Brochhausen C, Schulz B, Titze B, Abd Ali F, Pokupic S, Sievert KD, Hansen T.
Titze U, et al. Among authors: schneider f.
Int J Mol Sci. 2022 Oct 11;23(20):12103. doi: 10.3390/ijms232012103.
Int J Mol Sci. 2022.
PMID: 36292970
Free PMC article.
Item in Clipboard
Results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial).
Wiegel T, Albers P, Bartkowiak D, Bussar-Maatz R, Härter M, Kristiansen G, Martus P, Wellek S, Schmidberger H, Grozinger K, Renner P, Schneider F, Burmester M, Stöckle M.
Wiegel T, et al. Among authors: schneider f.
J Cancer Res Clin Oncol. 2021 Jan;147(1):235-242. doi: 10.1007/s00432-020-03327-2. Epub 2020 Sep 4.
J Cancer Res Clin Oncol. 2021.
PMID: 32886212
Free PMC article.
Clinical Trial.
Item in Clipboard
Termination rates and histological reclassification of active surveillance patients with low- and early intermediate-risk prostate cancer: results of the PREFERE trial.
Albers P, Wiegel T, Schmidberger H, Bussar-Maatz R, Härter M, Kristiansen G, Martus P, Meisner C, Wellek S, Grozinger K, Renner P, Burmester M, Schneider F, Stöckle M.
Albers P, et al. Among authors: schneider f.
World J Urol. 2021 Jan;39(1):65-72. doi: 10.1007/s00345-020-03154-7. Epub 2020 Mar 18.
World J Urol. 2021.
PMID: 32189088
Free PMC article.
Clinical Trial.
Item in Clipboard
Correction to: Results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial).
Wiegel T, Albers P, Bartkowiak D, Bussar-Maatz R, Härter M, Kristiansen G, Martus P, Wellek S, Schmidberger H, Grozinger K, Renner P, Schneider F, Burmester M, Stöckle M.
Wiegel T, et al. Among authors: schneider f.
J Cancer Res Clin Oncol. 2021 Jan;147(1):243-244. doi: 10.1007/s00432-020-03497-z.
J Cancer Res Clin Oncol. 2021.
PMID: 33346877
Free PMC article.
No abstract available.
Item in Clipboard
Ex Vivo Fluorescence Confocal Microscopy of MRI-Guided Targeted Prostate Biopsies for Rapid Detection of Clinically Significant Carcinomas-A Feasibility Study.
Titze U, Titze B, Hansen T, Barth PJ, Ali FA, Schneider F, Benndorf M, Sievert KD.
Titze U, et al. Among authors: schneider f.
Cancers (Basel). 2024 Feb 22;16(5):873. doi: 10.3390/cancers16050873.
Cancers (Basel). 2024.
PMID: 38473235
Free PMC article.
Item in Clipboard
Cite
Cite